Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.

Zimmer Biomet Holdings ... office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and ...

Zimmer Biomet, one of the largest orthopaedic medtech companies ... Joint replacement, a surgical procedure where an implant is used to fix an impacted joint, is usually recommended when ...

Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...

Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...

The Terminator actor teamed up with Zimmer Biomet to raise awareness about osteoarthritis, which affects more than 25 million ...

Zimmer Biomet Holdings ... with its orthopedics division contributing around $2.3 billion. Its knee and hip implant segments saw underlying growth rates of 1.3% and 4%, respectively, over 2023.

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...